Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 700 de 1076 resultados encontrados
Opções avançadas
Data de publicação: 17/04/2020 - 14:29
Enhancing the actions of the Oswaldo Cruz Foundation (Fiocruz) in the view of the new coronavirus pandemic (Sars-CoV-2) by joining the forces of the public and private sectors. This is the goal of the United against Covid-19 program launched by Fiocruz on April 2nd, opening a channel for companies, organizations and individuals interested in being a part of the network of supporters for the initiatives developed by the institution, all over...
Notícias
Data de publicação: 15/04/2020 - 11:18
With the aim of presenting innovative initiatives to respond to the pandemic, researchers from the Foundation participated, on March 31, in a virtual workshop with Portuguese-speaking countries, organized by the Research Capacity Network (REDe) and the sharing knowledge base incorporated into the online platform The Global Health Network, from the University of Oxford. The platform aims to provide research resources, courses and other tools...
Notícias
Data de publicação: 14/04/2020 - 14:25
On this Tuesday, April 14th is celebrated for the first time as the World Chagas Day, after being recognized in 2019 by the World Health Organization (WHO). To mark the day that remembers the first case diagnosed in humans by Fiocruz researcher Carlos Chagas, in 1909, leaders of Global Health have prepared a video. It is estimated that 6 to 7 million people worldwide suffer from Chagas disease, between 2 and 3 million of them live in Brazil....
Notícias
Data de publicação: 14/04/2020 - 09:51
The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the WHO and Fiocruz, the unit will now begin making confirmatory tests for the disease in the region, and will also join the WHO network of laboratory specialists for Covid-19. National...
Notícias
Data de publicação: 09/04/2020 - 16:00
A Fiocruz research has observed that the drug Atazanavir, used against HIV, was able to inhibit viral replication and to reduce the production of proteins that are related to the inflammatory process in the lungs, and therefore to the worsening of the clinical symptoms of the disease. Specialists have also looked into the combined use of atazanavir and ritonavir, another drug used to fight HIV. The study was published this Monday (April 6) on...
Notícias
Data de publicação: 06/04/2020 - 12:38
Fiocruz president, Nísia Trindade Lima, attended last Wednesday (April 1st) a meeting of global health leaders requested by the director-general of the World Health Organization, Tedros Adhanom. The goal of the meeting was to discuss the advancement of control measures in different countries, share lessons learned, and, mainly, debate future challenges involving the Covid-19 pandemic. The role of WHO in a post-quarantine transition was...
Notícias
Data de publicação: 06/04/2020 - 12:19
Fiocruz is now part of a group of more than 70 scientists and institutions of more than 30 countries in an international coalition to face the Covid-19 epidemic in countries with medium and low income. Launched last Thursday (02/04), the initiative, called Covid-19 Clinical Resarch Coalition, aims to speed up research on the new coronavirus in the areas where the virus may cause serious problems in health systems that are already fragile,...
Notícias
Data de publicação: 31/03/2020 - 14:34
The Foundation started the construction, in Rio de Janeiro, of the Hospital Center for the Covid-19 Pandemic - National Institute of Infectious Diseases, which will assist the state and municipal governments in fighting the disease. The rapid assembly hospital unit will have 200 beds exclusive for intensive and semi-intensive treatment of critical patients infected with the novel coronavirus (Sars-CoV-2). Check out a 3D view here. Built in...
Notícias
Data de publicação: 31/03/2020 - 13:18
On March 24, the Oswaldo Cruz Foundation launched an express approval process at the Brazilian Registry of Clinical Essays (ReBEC) for clinical research on the Covid-19. The so-called fast track may reduce the normal approval period, which normally takes up to a couple of weeks, to less than 48 hours. Scientists all over the world will be able to have quick access to the modeling of ongoing studies, thus avoiding re-working and...
Notícias
Data de publicação: 31/03/2020 - 12:52
In an interview to the Fiocruz News Agency (AFN), Nísia Trindade Lima comments on the context of the Covid-19 pandemics and the challenges of its arrival in Brazil. The Fiocruz president also lists some of the actions taken by the institution as a response to this public health crisis, from the production of tests to health care to those infected. All departments and units of the Foundation are mobilized to face the epidemics....
Notícias
Data de publicação: 30/03/2020 - 14:04
An unprecedented study, conducted by the research group on Health in the Prisions [Saúde nas Prisões] of the National School of Public Health (Ensp/Fiocruz), and coordinated by Alexandra Sánchez, through technical cooperation with the Public Prosecutor's Office/RJ, analyzed the causes of deaths in the Prison System of the State of Rio de Janeiro (2016-2017). The results indicate that infectious diseases were...
Notícias
Data de publicação: 30/03/2020 - 11:09
Articles on the new coronavirus (Sars-CoV-2) can be published in just 24 hours in the journal Memórias do Instituto Oswaldo Cruz, one of the oldest and most respected scientific journals in Latin America. Considering the importance of rapid data sharing during the pandemic, the journal provided an express way for the dissemination of research. Already used for work on Zika, chikungunya, yellow fever and Ebola, the Fast Track system...
Notícias
Data de publicação: 20/03/2020 - 13:24
The emergence of SARS-Cov-2 virus in Wuhan, China, in December 2019 led to a local epidemic that rapidly spread to multiple countries in the world, placing remarkable challenges in surveillance and control. On March 16th, 2020, WHO declared1 that the infection associated with SARS-Cov-2, named COVID-19, had spread to more than 100 countries, with more than 160,000 confirmed cases and more than 6,000 deaths globally. Great uncertainty...
Notícias
Data de publicação: 19/03/2020 - 14:18
The Oswaldo Cruz Foundation (Fiocruz) will be sending a team of professionals to Portuguese-speaking countries in Africa to help organise the response to the new coronavirus pandemic. This cooperation answers to a request by the regional office of the World Health Organization (WHO) in Africa, received by Fiocruz last Sunday (March 15). According to Fiocruz director of the Fiocruz Global Health Center, Paulo Buss, Brazilian and Portuguese...
Notícias
Data de publicação: 17/03/2020 - 13:56
Ten out of ten infectologists in the planet believe that one of the basic actions to avoid contamination by the Covid-19, more commonly known as coronavirus, is to stay away from large groups of people. This has led to the cancellation of numerous events such as sports events, concerts, conventions, and lessons in schools and universities. Even the healthy habit of going to the cinema has turned into a risky action. Now, what happens when you...
Notícias
Data de publicação: 16/03/2020 - 16:39
Health inequalities and challenges that science is facing nowadays were the common thread for the inaugural lecture for class 2020 at the Fiocruz National School of Public Health, held on March 4. Dr. Deisy Ventura, professor at the Faculty of Public Health of the University of São Paulo, was one of the main speakers in the event, which also had presentations from demographer Paulo Jannuzzi, from the Brazilian Institute of Geography and...
Notícias
Data de publicação: 03/03/2020 - 11:33
Given the emergence of agents with the capacity to cause diseases in humans, such as the new coronavirus, the Covid-19, scientists from all over the world have begun to work hard on the search for answers on the behavior of the pathogen. The process is similar to assembling a jigsaw puzzle: at every new research, an increasingly robust set of data takes form, contributing to clarify important characteristics that are crucial to create an...
Notícias
Data de publicação: 20/02/2020 - 14:09
Professors and researchers may apply for the scholarships under the Institutional Internationalization Program - PrInt Fiocruz-Capes. There are open selections for PhDs with Experience Abroad and for Visiting professor. The PhD with Experience Abroad aims to attract researchers with experience in a foreign country to work at Fiocruz, whose training and professional experience represent an innovative contribution to the Fiocruz Graduate...
Notícias
Data de publicação: 20/02/2020 - 12:06
Boletim Internacional
Data de publicação: 19/02/2020 - 15:55
A research by Fiocruz Minas has shown that Lamp, the test used to detect a series of infectious diseases, can also be used to diagnose human visceral leishmaniasis. The study by the PCPP, the Group of Clinical Researches and Public Policies on Infectious and Parasitic Diseases, was recently published in the BioMed Research International magazine. To verify the efficacy of the Lamp test, the researchers used the technique on blood samples that...
Notícias
Data de publicação: 19/02/2020 - 14:38
The Department of Policies for Pharmaceutical Drugs and Assistance (NAF) of the National School of Public Health (Ensp/Fiocruz) has been redesignated as a Collaborating Center of the Pan-American Health Organization (PAHO), part of the World Health Organization (WHO), in the area of Pharmaceutical Policies, at the end of 2019. Granted for the sixth time in a row, the redesignation is valid for a four-year period. The role played by NAF as a PAHO...
Notícias
Data de publicação: 19/02/2020 - 14:21
A group of researchers made a critical analysis of the current system of clinical classification of chikungunya cases. According to the scientists, with the emergency of the chikungunya virus transmission in the Americas beginning in 2013, it became clear that the classification of cases as acute, sub-acute and chronic has been insufficient, as it does not include the classification needs presented in some patients. In addition, this...
Notícias
Data de publicação: 18/02/2020 - 15:35
On February 8, the World Health Organization (WHO) revealed the results of its 2020 Dr. Lee Jong-wook Public Health award, won by the coordinator of the Global Network of Human Milk Banks (rBLH in the Brazilian Portuguese abbreviation) and researcher of the National Institute for the Health of Women, Children and Adolescents Fernandes Figueira (IFF/Fiocruz), João Aprígio Guerra de Almeida.   The award given by WHO pays...
Notícias
Data de publicação: 12/02/2020 - 11:36
With the inauguration of the new Comandante Ferraz Antarctica Station on January 15, Fiocruz now relies on a permanent laboratory in the continent. Fiolab is the result of a cooperation agreement signed with the Secretary of the Interministerial Commission for Marine Resources (Secirm/Brazilian Navy), and will be a biosafety laboratory prepared to respond to the country’s needs regarding epidemiological and public health surveillance and...
Notícias
Data de publicação: 12/02/2020 - 11:10
Fiocruz takes part on a meeting of hundreds of scientists from all over the world at the headquarters of the World Health Organization (WHO), in Geneva, on February 11 and 12, to discuss how research can be used to intensify efforts to combat the novel coronavirus. Fiocruz's president, Nísia Trindade Lima, is one of the chairpersons of the last day sessions, which will define the priorities of a global research agenda....
Notícias

Pages

Back to the topBack